--- title: "Avalyn Pharma (AVLN) news: IPO and offering" url: "https://aibio.space/companies/avalyn-pharma/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "AVLN IPO and offering news: Avalyn Pharma prices IPO of 16,666,667 shares at $18.00. Avalyn Pharma Inc. (NASDAQ: AVLN), United States." --- AVLN Avalyn Pharma Inc. NASDAQ · United States # Avalyn Pharma (AVLN) news AVLN IPO and offering news Financings · 2026-04-30 ## [Avalyn Pharma prices IPO of 16,666,667 shares at $18.00](https://aibio.space/news/avalyn-pharma-prices-ipo-16-666-667-shares-18-00/) The offering totals $300,000,006 before fees. The shares have been approved for listing on the Nasdaq Global Select Market as AVLN. ## Latest Avalyn Pharma news 1. 2026-04-08 Financings [Avalyn Pharma files for IPO, plans Nasdaq Global Market listing as AVLN](https://aibio.space/news/avalyn-pharma-files-ipo-plans-nasdaq-global-market-listing-avln/) Avalyn Pharma Inc. filed a Form S-1 on April 8, 2026. The cover leaves the share count and price range blank. ## Avalyn Pharma at a glance - **Ticker**: AVLN - **Listing**: NASDAQ - **Country**: United States ### Related companies - [Onconetix](https://aibio.space/companies/onconetix/) NASDAQ: ONCO - [Niki BioSolutions](https://aibio.space/companies/niki-biosolutions/) NASDAQ: NIKI - [Spyre Therapeutics](https://aibio.space/companies/spyre-therapeutics/) NASDAQ: SYRE - [CytoDyn](https://aibio.space/companies/cytodyn/) OTC: CYDY - [Akebia Therapeutics](https://aibio.space/companies/akebia-therapeutics/) NASDAQ: AKBA - [IDEAYA Biosciences](https://aibio.space/companies/ideaya-biosciences/) NASDAQ: IDYA - [CTT Pharmaceutical Holdings](https://aibio.space/companies/ctt-pharmaceutical/) OTC: CTTH - [Sonoma Pharmaceuticals](https://aibio.space/companies/sonoma-pharmaceuticals/) NASDAQ: SNOA ### Also on NASDAQ - [Q/C Technologies](https://aibio.space/companies/q-c-technologies/) QCLS - [Actuate Therapeutics](https://aibio.space/companies/actuate-therapeutics/) ACTU - [EXOZYMES INC.](https://aibio.space/companies/exozymes/) EXOZ - [Beyond Air](https://aibio.space/companies/beyond-air/) XAIR - [Traws Pharma](https://aibio.space/companies/traws-pharma/) TRAW - [Aclarion](https://aibio.space/companies/aclarion/) ACON ## Questions about Avalyn Pharma When did Avalyn Pharma go public? Our latest story on this, dated Apr 30, 2026: "Avalyn Pharma prices IPO of 16,666,667 shares at $18.00". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/avalyn-pharma-prices-ipo-16-666-667-shares-18-00/). Has Avalyn Pharma raised money recently? Our latest story on this, dated Apr 30, 2026: "Avalyn Pharma prices IPO of 16,666,667 shares at $18.00". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/avalyn-pharma-prices-ipo-16-666-667-shares-18-00/). What is the ticker symbol of Avalyn Pharma? Avalyn Pharma Inc. trades under the ticker AVLN on NASDAQ. Where is Avalyn Pharma listed? Avalyn Pharma Inc. is listed on NASDAQ. What is the SEC CIK of Avalyn Pharma? The SEC Central Index Key (CIK) for Avalyn Pharma Inc. is 1540171. Its filings are on SEC EDGAR. How many shares does Avalyn Pharma have outstanding? 44,333,095 shares as of 2026-08-31, per the cover page of its 10-Q filed 2026-08-12. Which country or territory is Avalyn Pharma listed under? Our directory records Avalyn Pharma Inc. under United States. What does Avalyn Pharma do? Our directory classifies Avalyn Pharma Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Avalyn Pharma? The ISIN recorded for Avalyn Pharma Inc. is US05348Y1055. Does aibio.space cover Avalyn Pharma? aibio.space lists Avalyn Pharma Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Avalyn Pharma incorporated? SEC records list its state or country of incorporation as DE. What is the latest Avalyn Pharma (AVLN) stock news? Our latest story on Avalyn Pharma, dated Apr 30, 2026: "Avalyn Pharma prices IPO of 16,666,667 shares at $18.00". The offering totals $300,000,006 before fees. The shares have been approved for listing on the Nasdaq Global Select Market as AVLN. [Source](https://aibio.space/news/avalyn-pharma-prices-ipo-16-666-667-shares-18-00/). How long will Avalyn Pharma's cash last? From our story of Apr 30, 2026: The prospectus says the net proceeds, together with existing cash and the $15.0 million borrowed, will fund operating expenses and capital requirements into 2029. [Source](https://aibio.space/news/avalyn-pharma-prices-ipo-16-666-667-shares-18-00/). How much cash does Avalyn Pharma have? From our story of Apr 30, 2026: At December 31, 2025, cash, cash equivalents and marketable securities totaled $138,359 thousand. [Source](https://aibio.space/news/avalyn-pharma-prices-ipo-16-666-667-shares-18-00/). Is Avalyn Pharma a smaller reporting company? SEC records list Avalyn Pharma Inc.'s filer category as:
Emerging growth company. ## Investor discussion: Avalyn Pharma Members talk about Avalyn Pharma (AVLN). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Avalyn Pharma, newest first. Each line links the filing it comes from. 1. 2026-04-30 Financings Filed a final prospectus for a securities offering. SEC Form 424B4. [Source](https://www.sec.gov/Archives/edgar/data/1540171/000119312526197686/424b4.htm) 2. 2026-04-08 Financings Filed a registration statement for a share offering. SEC Form S-1. [Source](https://www.sec.gov/Archives/edgar/data/1540171/000119312526147573/ck0001540171-20260408.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:AVLN on TradingView](https://www.tradingview.com/symbols/NASDAQ-AVLN/). ## SEC filings and registration - **SEC name**: Avalyn Pharma Inc. - **CIK**: 1540171 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: AVLN (Nasdaq) - **State or country of incorporation**: DE - **Fiscal year ends**: December 31 - **Filer category**:
Emerging growth company - **Business address**: 105 W FIRST ST., BOSTON, MA, 02127 - **Phone**: (206) 707-0340 - **Shares outstanding**: 44,333,095 as of 2026-08-31 (10-Q filed 2026-08-12) - **Former names**: Genoa Pharmaceuticals, Inc. ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/1540171/000119312526393081/ck0001540171-20260915.htm) filed 2026-09-16 - [10-Q](https://www.sec.gov/Archives/edgar/data/1540171/000119312526345820/ck0001540171-20260630.htm) filed 2026-08-12 - [8-K](https://www.sec.gov/Archives/edgar/data/1540171/000119312526345807/ck0001540171-20260812.htm) filed 2026-08-12 - [8-K](https://www.sec.gov/Archives/edgar/data/1540171/000119312526292834/ck0001540171-20260629.htm) filed 2026-07-01 - [8-K](https://www.sec.gov/Archives/edgar/data/1540171/000119312526273405/ck0001540171-20260617.htm) filed 2026-06-17 - [10-Q](https://www.sec.gov/Archives/edgar/data/1540171/000119312526254623/ck0001540171-20260331.htm) filed 2026-06-03 - [8-K](https://www.sec.gov/Archives/edgar/data/1540171/000119312526254581/ck0001540171-20260603.htm) filed 2026-06-03 - [8-K](https://www.sec.gov/Archives/edgar/data/1540171/000119312526201434/ck0001540171-20260501.htm) filed 2026-05-01 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001540171), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Avalyn Pharma Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker AVLN, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Avalyn Pharma Inc. - **Ticker**: AVLN - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Pharmaceuticals: Major - **ISIN**: US05348Y1055 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-AVLN/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/avalyn-pharma/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Avalyn Pharma (AVLN) news: IPO and offering", 2026-10-31, https://aibio.space/companies/avalyn-pharma/